Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Immunochina
company
About
Immunochina Pharmaceuticals produces cell injections, cell therapy drugs, and other products and provides medical technology development.
- 1 - 10
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- ¥140M
- Industries
- Biotechnology,Clinical Trials,Medical,Medical Device,Pharmaceutical
- Founded date
- Apr 1, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
ImmunoChina Pharmaceuticals manufactures medical products. The Company produces cell injections, cell therapy drugs, and other products. ImmunoChina Pharmaceuticals also provides medical technology development, medical research, medical trial development, and other services.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
¥140M $7.50M
Immunochina has raised a total of
¥140M $7.50M
in funding over 2 rounds. Their latest funding was raised on
Nov 24, 2021 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 24, 2021 | Series D | — | 1 | — | — | Detail |
| Jan 22, 2019 | Series C | ¥140M | 2 |
|
— | Detail |
| Nov 24, 2017 | Series B | $7.50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
2
4
Immunochina is funded by 4 investors.
Qingzhe Capital
and China-Belgium Direct Equity Investment Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series C |
|
|
Yes | Series C |
Yajie Shanghui
|
— | Series D |
ShengJing360
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
